- Home
- CNTX vs ZENV Comparison
CNTX vs ZENV Comparison
Compare CNTX & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- ZENV
- Stock Information
- Founded
- CNTX 2015
- ZENV 2005
- Country
- CNTX United States
- ZENV Brazil
- Employees
- CNTX N/A
- ZENV N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- ZENV Computer Software: Prepackaged Software
- Sector
- CNTX Health Care
- ZENV Technology
- Exchange
- CNTX Nasdaq
- ZENV Nasdaq
- Market Cap
- CNTX 78.0M
- ZENV 80.2M
- IPO Year
- CNTX 2021
- ZENV 2021
- Fundamental
- Price
- CNTX $0.58
- ZENV $1.23
- Analyst Decision
- CNTX Strong Buy
- ZENV
- Analyst Count
- CNTX 4
- ZENV 0
- Target Price
- CNTX $6.00
- ZENV N/A
- AVG Volume (30 Days)
- CNTX 164.6K
- ZENV 92.4K
- Earning Date
- CNTX 05-07-2025
- ZENV 05-16-2025
- Dividend Yield
- CNTX N/A
- ZENV N/A
- EPS Growth
- CNTX N/A
- ZENV N/A
- EPS
- CNTX N/A
- ZENV N/A
- Revenue
- CNTX N/A
- ZENV $155,164,999.00
- Revenue This Year
- CNTX N/A
- ZENV $11.50
- Revenue Next Year
- CNTX N/A
- ZENV $10.28
- P/E Ratio
- CNTX N/A
- ZENV N/A
- Revenue Growth
- CNTX N/A
- ZENV 18.83
- 52 Week Low
- CNTX $0.49
- ZENV $1.02
- 52 Week High
- CNTX $2.75
- ZENV $3.38
- Technical
- Relative Strength Index (RSI)
- CNTX 33.91
- ZENV 38.66
- Support Level
- CNTX $0.49
- ZENV $1.20
- Resistance Level
- CNTX $0.71
- ZENV $1.30
- Average True Range (ATR)
- CNTX 0.08
- ZENV 0.13
- MACD
- CNTX -0.02
- ZENV -0.03
- Stochastic Oscillator
- CNTX 33.31
- ZENV 17.12
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.